Skip to main content
Hit enter to search or ESC to close
Close Search
search
account
0
Menu
Browse Reports
Syndicated Research
Clinical Trials
Manufacturing
Pharmaceutical Department Structures
Technology
Subscription Plans
Custom Market Research
Brand Health
Brand Health Case Study
Customer Perception
Customer Satisfaction
Emotional Brand Profile
Message Testing
New Product Development
Persona Development
Persona Development Case Study
Customer Decision-Making Assessment Case Study
Thought Leadership
Win/Loss Analysis
Win/Loss Case Study
Resources
Core Industry Metrics
eBooks
Industry Articles
Industry Statistics
Infographics
Whitepapers
Health Panel
About
Careers
Contact Us
Community Involvement
Login
Search Reports
search
account
0
was successfully added to your cart.
[account_shop_links]
Browse Reports
Syndicated Research
Clinical Trials
Manufacturing
Pharmaceutical Department Structures
Technology
Subscription Plans
Custom Market Research
Brand Health
Brand Health Case Study
Customer Perception
Customer Satisfaction
Emotional Brand Profile
Message Testing
New Product Development
Persona Development
Persona Development Case Study
Customer Decision-Making Assessment Case Study
Thought Leadership
Win/Loss Analysis
Win/Loss Case Study
Resources
Core Industry Metrics
eBooks
Industry Articles
Industry Statistics
Infographics
Whitepapers
Health Panel
About
Careers
Contact Us
Community Involvement
Home
»
Industry Statistics
Resources
Industry Statistics
All
Industry Statistics
Attributes Gaining Importance When Selecting Among Preferred Providers for Phase I Services
Attributes Gaining Importance When Selecting Among Preferred Providers for Phase I Services
Attributes Gaining Importance When Selecting Among Preferred Providers for Phase I Services
Decentralized Clinical Trial Predicted Use
Decentralized Clinical Trial Predicted Use
Decentralized Clinical Trial Predicted Use
How Well Are CDMOs Performing on Sponsors’ Most Important CDMO Selection Criteria
How Well Are CDMOs Performing on Sponsors’ Most Important CDMO Selection Criteria
How Well Are CDMOs Performing on Sponsors’ Most Important CDMO Selection Criteria
Clinical Manufacturing Volume by Service Provider Category
Clinical Manufacturing Volume by Service Provider Category
Clinical Manufacturing Volume by Service Provider Category
Phase I Study Complexity
Phase I Study Complexity
Phase I Study Complexity
The Top Reasons Bioprocessing CDMOs Lose Bids
The Top Reasons Bioprocessing CDMOs Lose Bids
The Top Reasons Bioprocessing CDMOs Lose Bids
Preferred Provider Agreements at Small & Emerging Sponsors
Preferred Provider Agreements at Small & Emerging Sponsors
Preferred Provider Agreements at Small & Emerging Sponsors
Outsourced Proportion of Phase II/III Spend
Outsourced Proportion of Phase II/III Spend
Outsourced Proportion of Phase II/III Spend
Volume of Trials with Outsourced Clinical Logistics
Volume of Trials with Outsourced Clinical Logistics
Volume of Trials with Outsourced Clinical Logistics
Predicted Changes in Outsourcing Rates for Highly Potent API
Predicted Changes in Outsourcing Rates for Highly Potent API
Predicted Changes in Outsourcing Rates for Highly Potent API
Phase II/III Service Provider Attributes Gaining in Selection Importance
Phase II/III Service Provider Attributes Gaining in Selection Importance
Phase II/III Service Provider Attributes Gaining in Selection Importance
Preferred Provider Agreements for Phase I Services
Preferred Provider Agreements for Phase I Services
Preferred Provider Agreements for Phase I Services
